Struma ovarii with follicular thyroid-type carcinoma and neuroendocrine component: case report

World Journal of Surgical Oncology

Paolo Innocenti²  Roberto Cotellese²  Alberto D’Aulerio²  Domenico Angelucci¹  Daniela Simo²  Mathew Waku²  Domenico Risio²  Federico Selvaggi² 

[1] Unit of Pathology, “G. d’Annunzio” University, Chieti, Italy;Unit of General and Laparoscopic Surgery, Biomedical Sciences Department, “G. d’Annunzio” University, Via dei Vestini 31, Chieti, 66100, Italy

关键词: Bilateral salpingo-oophorectomy;    Hysterectomy;    Follicular thyroid carcinoma;    Struma ovarii;   

Others  :  827744
DOI  :  10.1186/1477-7819-10-93

 received in 2012-01-24, accepted in 2012-04-09,  发布年份 2012

【 摘 要 】

Struma ovarii (SO) is a slow-growing ovarian neoplasm with thyroid tissue as its predominant component. It is an uncommon neoplasm, usually asymptomatic with an unknown risk of malignant transformation. Due to difficulties in assessing the rare biological nature and the discrepancies in the reported cases, a consensus on the appropriate treatment has not been definitively reached.

A 50-year-old female was subjected to upper gut endoscopy which showed a 30-mm mass located in the gastric antrum, suggestive of mesenchimal tumor. Incidentally, a pelvic CT scan also documented a solid mass in the right adnexa, with morphological characteristics of ovarian neoplasm. The patient underwent gastrectomy, total hysterectomy, bilateral salpingo-oophorectomy with lymph node dissection, and omentectomy. Histology documented the presence of gastric cavernous angioma, and, in the right adnexa, foci of follicular thyroid-type carcinoma arising in SO with a well-differentiated neuroendocrine component.

Here we report and discuss the clinical and morphological presentation of follicular thyroid-type carcinoma arising in SO. The neoplasm was discovered incidentally and had a favorable clinical outcome at 1-year follow-up.

【 授权许可】

   
2012 Selvaggi et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Navarro MD, Tan MAL, Lovecchio JL, Hajdu SI: Case report: malignant struma ovarii. Ann Clin Lab Sci 2004, 34(1):107-112.
• [2]Roth LM, Talerman A: The enigma of struma ovarii. Pathology 2007, 39(1):139-146.
• [3]Doganay M, Gungor T, Cavkaytar S, Sirvan L, Mollamahmutoglu L: Malignant struma ovarii with focus of papillary thyroid cancer: a case report. Arch Gynecol Obstet 2008, 277:371-373.
• [4]Salman WD, Singh M, Twaij Z: A case of papillary thyroid carcinoma in struma ovarii and review of the literature. Patholog Res Int 2010, :352476.
• [5]Makani S, Kim W, Gaba AR: Struma Ovarii with a focus of papillary thyroid cancer: a case report and review of the literature. Ginecol Oncol 2004, 94:835-839.
• [6]Kraemer B, Grischke EM, Staebler A, Hirides P, Rothmund R: Laparoscopic excision of malignant struma ovarii and 1 year follow-up without further treatment. Fertil Steril 2011, 95(6):2124. e9-e12
• [7]Celestino R, Magalhães J, Castro P, Triller M, Vinagre J, Soares P, Sobrinho-Simões M: A follicular variant of papillary thyroid carcinoma in struma ovarii. Case report with unique molecular alterations. Histopathology 2009, 55(4):482-487.
• [8]Marcy PY, Thariat J, Benisvy D, Azuar P: Lethal, malignant, metastatic struma ovarii. Thyroid 2010, 10(9):1037-1040.
• [9]Zhang X, Axiotis C: Thyroid-Type Carcinoma of Struma Ovarii. Arch Pathol Lab Med 2010, 134:786-791.
• [10]Boutross-Tadross O, Saleh R, Asa SL: Follicular variant papillary thyroid carcinoma arising in struma ovarii. Endocr Pathol 2007, 18:182-186.
• [11]Yassa L, Sadow P, Marqusee E: Malignant struma ovarii. Nat Clin Pract Endocrinol Metab 2008, 4(8):469-472.
• [12]Yoo S-C, Chang Ki-Hong, Lyu Mi-Ok, Chang S-J, Ryu H-S, Kim H-S: Clinical characteristics of struma ovarii. J Gynecol Oncol 2008, 19(2):135-138.
• [13]Matsuda K, Maehama T, Kanazawa K: Malignant struma ovarii with thyrotoxicosis. Gynecol Oncol 2001, 82:575-577.
• [14]Shen J, Xia X, Lin Y, Zhu W, Yuan J: Diagnosis of Struma ovarii with medical imaging. Abdom Imaging 2011, 36:627-631.